a phase ib trial of fixed-volume isatuximab infusion in newly-diagnosed multiple myeloma
Published 3 years ago • 14 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
2:09
fixed-volume isatuximab infusion in newly-diagnosed myeloma
-
6:37
phase iii trial of rvd induction with or without isatuximab in newly diagnosed myeloma
-
2:10
overview of a phase ii clinical trial of isatuximab
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
3:20
phase i trial of a bcma-cd3 bispecific antibody in r/r myeloma
-
2:30
a new era of treatment for multiple myeloma
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
55:45
phase ii clinical trials
-
36:40
what a newly diagnosed patient needs to know
-
4:38
ovg research: legacy
-
1:39
phase i/ii trial of adct-602 in b-all
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
4:00
optimizing the outcomes of autohsct in multiple myeloma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:41
emerging therapies for r/r myeloma
-
2:48
an overview of trials in progress in al amyloidosis: highlights from isa 2024
-
5:24
ifm 209 update: 4-year extended follow-up of transplantation outcomes in myeloma
-
1:00
proof of principle to progress treatments